Access the full text.
Sign up today, get DeepDyve free for 14 days.
B. Gutfilen, Sergio Souza, G. Valentini (2018)
Copper-64: a real theranostic agentDrug Design, Development and Therapy, 12
F. Paparo, Alice Peirano, João Matos, L. Bacigalupo, U. Rossi, I. Mussetto, G. Bottoni, Martina Ugolini, C. Introini, F. Ruggieri, G. Rollandi, A. Piccardo (2020)
Diagnostic value of retrospectively fused 64CuCl2 PET/MRI in biochemical relapse of prostate cancer: comparison with fused 18F-Choline PET/MRI, 64CuCl2 PET/CT, 18F-Choline PET/CT, and mpMRIAbdominal Radiology, 45
R. Safi, E. Nelson, S. Chitneni, K. Franz, D. George, M. Zalutsky, D. McDonnell (2014)
Copper signaling axis as a target for prostate cancer therapeutics.Cancer research, 74 20
(2019)
Detection efficacy of (18)F-PSMA-1007 PET/CT in 251 patients with biochemical recurrence of prostate cancer after radical prostatectomy
A. Parmar, G. Pascali, F. Voli, L. Lerra, Eugene Yee, Aria Ahmed-Cox, Kathleen Kimpton, G. Cirillo, Andrew Arthur, D. Zahra, G. Rahardjo, Guo-Jun Liu, Nigel Lengkeek, F. Saletta, A. Charil, M. Kavallaris, O. Vittorio (2018)
In vivo [64Cu]CuCl2 PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasisTheranostics, 8
C. Qin, Hongguang Liu, Kai Chen, Xiang Hu, Xiaowei Ma, X. Lan, Yongxue Zhang, Zhen Cheng (2014)
Theranostics of Malignant Melanoma with 64CuCl2The Journal of Nuclear Medicine, 55
N. Solomons (1985)
Biochemical, metabolic, and clinical role of copper in human nutrition.Journal of the American College of Nutrition, 4 1
(2018)
Diagnostic accuracy of 68 Ga-PSMA-11 PET/MRI compared with multiparametric MRI in the detection of prostate cancer
Kristoffer Kjærgaard, T. Sandahl, K. Frisch, K. Vase, S. Keiding, H. Vilstrup, P. Ott, L. Gormsen, O. Munk (2020)
Intravenous and oral copper kinetics, biodistribution and dosimetry in healthy humans studied by [64Cu]copper PET/CTEJNMMI Radiopharmacy and Chemistry, 5
F. Ceci, W. Fendler, M. Eiber (2017)
A New Type of Prostate Cancer Imaging: Will 64CuCl2 PET/CT Flourish or Vanish?The Journal of Nuclear Medicine, 59
Haiyuan Zhang, H. Cai, Xin Lu, O. Muzik, Fangyu Peng (2011)
Positron emission tomography of human hepatocellular carcinoma xenografts in mice using copper (II)-64 chloride as a tracer with copper (II)-64 chloride.Academic radiology, 18 12
F. Giesel, K. Knorr, Fabian Spohn, Leon Will, T. Maurer, P. Flechsig, O. Neels, K. Schiller, H. Amaral, W. Weber, U. Haberkorn, M. Schwaiger, C. Kratochwil, P. Choyke, V. Kramer, K. Kopka, M. Eiber (2018)
Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical ProstatectomyJournal of Nuclear Medicine, 60
Donita Brady, Matt Crowe, Michelle Turski, Aaron Hobbs, Xiaojie Yao, A. Chaikuad, S. Knapp, K. Xiao, S. Campbell, D. Thiele, C. Counter (2014)
Abstract IA09: Copper is required for oncogenic BRAF signaling and tumorigenesisMolecular Cancer Research, 12
D. Schuster, J. Votaw, P. Nieh, Weiping Yu, J. Nye, V. Master, F. Bowman, M. Issa, M. Goodman (2007)
Initial experience with the radiotracer anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid with PET/CT in prostate carcinoma.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 48 1
(2006)
Positron emission tomography of human prostate cancer xenografts in mice with increased uptake of copper (II)-64 chloride
(2022)
phase IIa clinical study
F. García-Pérez, S. Medina-Ornelas, F. Barrón-Barrón, Oscar Arrieta-Rodríguez (2020)
Evaluation of non-small cell lung cancer by PET/CT with 64CuCl2: initial experience in humans.American journal of nuclear medicine and molecular imaging, 10
S. Apelgot, J. Coppey, A. Gaudemer, J. Grisvard, E. Guillé, I. Sasaki, I. Sissoeff (1989)
Similar lethal effect in mammalian cells for two radioisotopes of copper with different decay schemes, 64Cu and 67Cu.International journal of radiation biology, 55 3
Qiang Wang, Dongli Song, Xiaowei Ma, Xiaodong Wu, Lei Jiang (2020)
Preclinical PET imaging study of lung cancer with 64CuCl2Annals of Nuclear Medicine, 34
E. Capasso, S. Durzu, S. Piras, S. Zandieh, P. Knoll, A. Haug, M. Hacker, C. Meleddu, S. Mirzaei (2015)
Role of 64CuCl2 PET/CT in staging of prostate cancerAnnals of Nuclear Medicine, 29
S. Righi, Martina Ugolini, G. Bottoni, M. Puntoni, M. Iacozzi, F. Paparo, M. Cabria, L. Ceriani, M. Gambaro, L. Giovanella, A. Piccardo (2018)
Biokinetic and dosimetric aspects of 64CuCl2 in human prostate cancer: possible theranostic implicationsEJNMMI Research, 8
Catarina Pinto, S. Bucar, V. Alves, Alexandra Fonseca, A. Abrunhosa, C. Silva, J. Guerreiro, F. Mendes (2020)
Copper-64 Chloride Exhibits Therapeutic Potential in Three-Dimensional Cellular Models of Prostate CancerFrontiers in Molecular Biosciences, 7
G. Souliotis, M.R.D. Rodrigues, M.R.D. Rodrigues, K. Wang, V. Iacob, N. Nica, Brian Roeder, G. Tabacaru, M. Yu, P. Zanotti-Fregonara, A. Bonasera (2019)
A novel approach to medical radioisotope production using inverse kinematics: A successful production test of the theranostic radionuclide 67Cu.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 149
J. Guerreiro, V. Alves, A. Abrunhosa, A. Paulo, O. Gil, F. Mendes (2018)
Radiobiological Characterization of 64CuCl2 as a Simple Tool for Prostate Cancer TheranosticsMolecules, 23
C. Ferrari, A. Asabella, C. Villano, B. Giacobbi, D. Coccetti, P. Panichelli, G. Rubini (2015)
Copper-64 Dichloride as Theranostic Agent for Glioblastoma Multiforme: A Preclinical StudyBioMed Research International, 2015
J. Jørgensen, Morten Persson, J. Madsen, A. Kjær (2013)
High tumor uptake of (64)Cu: implications for molecular imaging of tumor characteristics with copper-based PET tracers.Nuclear medicine and biology, 40 3
F Peng (2006)
1649J Nucl Med, 47
(2015)
Role of 64CuCl 2 PET/CT in staging of prostate cancer
(2005)
Mouse extrahepatichepatoma detected on MicroPET using copper (II)-64 chloride uptake mediated by endogenous mouse copper transporter
P. Panichelli, C. Villano, A. Cistaro, A. Bruno, F. Barbato, A. Piccardo, A. Duatti (2016)
Imaging of Brain Tumors with Copper-64 Chloride: Early Experience and Results.Cancer biotherapy & radiopharmaceuticals, 31 5
A. Piccardo, F. Paparo, M. Puntoni, S. Righi, G. Bottoni, L. Bacigalupo, S. Zanardi, A. Decensi, Giulia Ferrarazzo, M. Gambaro, F. Ruggieri, F. Campodonico, L. Tomasello, L. Timossi, S. Sola, E. Lopci, M. Cabria (2018)
64CuCl2 PET/CT in Prostate Cancer RelapseThe Journal of Nuclear Medicine, 59
(2021)
Efficacy and safety of the 64Cu(II)Cl2 PET/CT for urological malignancies: phase IIa clinical study
D. Medvedev, L. Mausner, G. Meinken, S. Kurczak, H. Schnakenberg, C. Dodge, E. Korach, S. Srivastava (2012)
Development of a large scale production of 67Cu from 68Zn at the high energy proton accelerator: closing the 68Zn cycle.Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine, 70 3
Fangyu Peng, Jianguo Liu, Jiu-sheng Wu, Xin Lu, O. Muzik (2005)
Mouse Extrahepatic Hepatoma Detected on MicroPET Using Copper (II)-64 Chloride Uptake Mediated by Endogenous Mouse Copper Transporter 1Molecular Imaging and Biology, 7
Robert Hicks, J. Simko, A. Westphalen, Hao Nguyen, Kirsten Greene, Li Zhang, P. Carroll, T. Hope (2018)
Diagnostic Accuracy of 68Ga-PSMA-11 PET/MRI Compared with Multiparametric MRI in the Detection of Prostate Cancer.Radiology, 289 3
(2018)
CuCl(2) PET imaging reveals activity of Dextran-Catechin on tumor copper homeostasis
A. Wachnik (1988)
The physiological role of copper and the problems of copper nutritional deficiency.Die Nahrung, 32 8
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
DC Brady (2014)
492Nature, 509
K. Kim, S. Jang, Ju Park, Y. Lee, T. Lee, K. Woo, Hyun Park, J. Choe, G. An, J. Kang (2014)
Detection of Increased 64Cu Uptake by Human Copper Transporter 1 Gene Overexpression Using PET with 64CuCl2 in Human Breast Cancer Xenograft ModelThe Journal of Nuclear Medicine, 55
H. Cai, Jiu-sheng Wu, O. Muzik, J. Hsieh, Robert Lee, Fangyu Peng (2014)
Reduced 64Cu Uptake and Tumor Growth Inhibition by Knockdown of Human Copper Transporter 1 in Xenograft Mouse Model of Prostate CancerThe Journal of Nuclear Medicine, 55
Copper is required for cancer cell proliferation and tumor angiogenesis. Radioactive copper-64 chloride (64CuCl2) is a useful radiotracer for cancer imaging with position emission tomography (PET) based on increased cellular uptake of copper mediated by human copper transporter 1 (hCtr1) expressed on cancer cell membrane. Significant progress has been made in research of using 64CuCl2 as a radiotracer for cancer imaging with PET. Radiation dosimetry study in humans demonstrated radiation safety of 64CuCl2. Recently, 64CuCl2 was successfully used for PET imaging of prostate cancer, bladder cancer, glioblastoma multiforme (GBM), and non-small cell lung carcinoma in humans. Based on the findings from the preclinical research studies, 64CuCl2 PET/CT also holds potential for diagnostic imaging of human hepatocellular carcinoma (HCC), malignant melanoma, and detection of intracranial metastasis of copper-avid tumors based on low physiological background of radioactive copper uptake in the brain. Copper-64 radionuclide emits both β+ and β− particles, suggesting therapeutic potential of 64CuCl2 for radionuclide cancer therapy of copper-avid tumors. Recent progress in production of therapeutic copper-67 radionuclide invites clinical research in use of theranostic pair of 64CuCl2 and 67CuCl2 for cancer imaging and radionuclide therapy.
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Apr 1, 2022
Keywords: Positron emission tomography; Copper-64 chloride; Prostate cancer; Bladder cancer; Glioblastoma multiforme; Radionuclide therapy
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.